『#394 How Newborn Sequencing Could Transform Pediatric Rare Disease Care in Florida』のカバーアート

#394 How Newborn Sequencing Could Transform Pediatric Rare Disease Care in Florida

#394 How Newborn Sequencing Could Transform Pediatric Rare Disease Care in Florida

無料で聴く

ポッドキャストの詳細を見る
Newborn sequencing is no longer just a future-facing idea discussed in genetics circles. It is beginning to take shape through real pilot programs, state policy, and health system efforts exploring how genomics could fit into routine newborn care. In this episode of DNA Today, we take a closer look at one example of that momentum: Florida’s Sunshine Genetics Act. The legislation created a five-year, voluntary newborn genetic sequencing pilot program and established the Sunshine Genetics Consortium. The program allows parents to opt in to newborn genetic screening, including whole genome sequencing. The state allocated millions for the Sunshine Genetics Pilot Program, along with additional funding for the Florida Institute for Pediatric Rare Diseases. To unpack what this could mean for rare disease diagnosis, pediatric genomic medicine, and the future of newborn screening, our host Kira Dineen is joined by Dr. Pradeep Bhide, Director of the Florida Institute for Pediatric Rare Diseases, and State Representative Adam Anderson, who championed the legislation after losing his son Andrew to Tay-Sachs disease at age 4. About Our Guests Dr. Pradeep G. Bhide is the Jim and Betty Ann Rodgers Eminent Scholar Chair of Developmental Neuroscience, Director of the Florida Institute for Pediatric Rare Diseases, and Director of the Center for Brain Repair at the Florida State University College of Medicine. His work focuses on developmental neuroscience, pediatric rare disease research, precision diagnostics, and advancing treatments for children and families affected by rare genetic conditions. Representative Adam Anderson represents District 57 in the Florida House of Representatives. He sponsored and championed the Sunshine Genetics Act, drawing from his family’s personal experience with rare disease after the loss of his son Andrew to Tay-Sachs disease. Through this legislation, Representative Anderson has helped position Florida as one of the first states to explore how genomic sequencing could be integrated into newborn screening and pediatric rare disease care. In This Episode, We Discuss: How Representative Anderson’s son Andrew inspired his advocacy for newborn sequencing and rare disease legislationWhat the Sunshine Genetics Act makes possible for families in FloridaHow newborn genome sequencing could shorten or prevent the rare disease diagnostic odysseyThe role of the Sunshine Genetics Consortium in coordinating researchers, clinicians, geneticists, children’s hospitals, and biotech innovators across the stateWhy early genomic diagnosis can influence medical management, specialist referrals, surveillance, treatment planning, and access to clinical trialsHow Florida’s approach fits into the broader global movement toward newborn sequencing, alongside programs such as Genomics England’s Generation Study, GUARDIAN in New York, BeginNGS at Rady Children’s, and NIH-funded BEACONSWhat “whole genome sequencing” means in the context of this pilot, and how programs may distinguish between sequencing the whole genome and analyzing a targeted set of genesHow families may be educated about voluntary participation and informed consentWhat types of results may be returned to parents and healthcare practitionersHow programs are thinking about childhood-onset, treatable, preventable, and potentially adult-onset findingsThe connection between earlier diagnosis and emerging gene-based therapiesWhat it takes to move complex genomic medicine legislation forwardHow Florida is building infrastructure for pediatric genomic medicineWhich outcomes will matter most as the five-year pilot unfolds, including enrollment, sequencing metrics, clinical impact, public health impact, cost effectiveness, and economic benefits, which are included in the reporting requirements for the program. Why This Conversation Matters For many families affected by rare disease, the search for a diagnosis can take years. Those years can include specialist visits, inconclusive testing, missed opportunities for early intervention, and emotional strain. Newborn sequencing raises the possibility of identifying certain serious genetic conditions before symptoms appear, allowing families and clinicians to act sooner. At the same time, implementing newborn sequencing brings important questions: What conditions should be included? What results should be returned? How should parents be consented? How will privacy and data use be handled? What infrastructure is needed to support follow-up care? And how can programs ensure equitable access? Relevant Resources: “Florida surges to forefront of rare disease research with boost from Sunshine Genetics Act” via Florida State University News“Florida Becomes The First State To Scan For Genetic Diseases In All Newborns” via ForbesThe Florida Institute for Pediatric Rare Diseases; the Sunshine Genetics Pilot Program; the Sunshine Genetics ConsortiumThe International Consortium on Newborn ...
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません